Primary Site >> Pancreatic Cancer
Gene >> CCK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: [Pancreatic secretion of patients with chronic renal insufficiency (author's transl)]. PMID: 1142706 |
Ref: Prospective evaluation of the pancreatic secretion of immunoreactive carcinoembryonic antigen, enzyme, and bicarbonate in patients suspected of having pancreatic cancer. PMID: 892342 Ref: The CEA concentration in duodenal fluid in patients with pancreatic disease. PMID: 929116 |
Ref: A comparative evaluation of endoscopic retrograde pancreatography and secretin-CCK test in the diagnosis of pancreatic disease. PMID: 725498 Ref: The secretin-CCK test and a modified Lundh test. A comparative study. PMID: 725516 |
Ref: Duodenal calcium outputs in health and pancreatic disease. PMID: 7429325 |
Ref: Pancreatic secretions as a clue to the presence of pancreatic cancer. PMID: 7272914 Ref: Pancreatic cancer: diagnostic value of pancreatic function tests. PMID: 7349807 |
Ref: Trophic effects of cholecystokinin octapeptide on the pancreas of the Syrian hamster. PMID: 6176305 Ref: Protein secretions in hamsters with pancreatic carcinoma. PMID: 7075431 |
Ref: Treatment with secretin and a cholecystokinin-like peptide in patients with pancreatic cancer. A pilot study. PMID: 6085189 |
Ref: [Insulin--a regulator of exocrine pancreas function?]. PMID: 3911614 Ref: Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model. PMID: 3966964 |
Ref: Effect of cholecystokinin on pancreatic carcinogenesis in the hamster model. PMID: 2833367 Ref: Bombesin inhibits growth of human pancreatic adenocarcinoma in nude mice. PMID: 2838842 |
Ref: The effect of gastrointestinal hormones on the incorporation of tritiated thymidine in the pancreatic adenocarcinoma cell line (WD PaCa). PMID: 2600453 |
Ref: Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990. PMID: 2226098 |
Ref: Specific binding of cholecystokinin, estradiol and somatostatin to human pancreatic cancer xenografts. PMID: 1683561 Ref: Effects of cholecystokinin on cytosolic calcium in human pancreatic cancer cells. PMID: 1805301 Ref: CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium. PMID: 1866474 Ref: [Changes of responses of gastrointestinal hormones after pancreatectomies]. PMID: 1944186 Ref: Effects of pancreastatin (24-49) on growth of normal pancreas and pancreatic cancer. PMID: 1946312 Ref: Perspectives of CCK antagonists in pancreatic research and clinical use. Part I. PMID: 2051061 |
Ref: Survey of neuropeptide gene expression in tumor cell lines. PMID: 1320892 Ref: Trophic effects of unsulfated cholecystokinin on mouse pancreas and human pancreatic cancer. PMID: 1381096 Ref: Duodenogastric reflux enhances growth and carcinogenesis in the rat pancreas. PMID: 1393475 Ref: Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization. PMID: 1458479 Ref: [Effects of UFT and loxiglumide (CR1505) on liver metastasis of human pancreatic cancer cell line, KP-1 N in nude mice]. PMID: 1503487 Ref: Effect of CCK receptor antagonist on growth of pancreatic adenocarcinoma. PMID: 1528048 Ref: A pilot clinical trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer. PMID: 1553366 Ref: Cholecystokinin inhibits DNA alkylation induced by N-nitrosobis (2-oxopropyl)amine (BOP) in hamster pancreas. PMID: 1596869 Ref: Overexpression of cholecystokinin receptors in azaserine-induced neoplasms of the rat pancreas. PMID: 1596887 Ref: [Applicability of CCK receptor antagonists in physiologic and therapeutic studies]. PMID: 1632116 |
Ref: Temporal expression of the gastrin (CCK-B) receptor during azaserine-induced pancreatic carcinogenesis. PMID: 8302799 Ref: Cholecystokinin receptors and PANC-1 human pancreatic cancer cells. PMID: 8338163 Ref: Inhibitory effects of a cholecystokinin antagonist, loxiglumide (CR-1505), on the growth of freshly separated and xenografted human pancreatic cancer. PMID: 8386784 Ref: Severe subcellular damage in the rat exocrine pancreas after pancreatobiliary diversion. PMID: 8483876 Ref: [Effect of cholecystokinin and secretin on insulin binding to rat pancreatic acini and pancreatic cancer cell line AR42J cells]. PMID: 8515582 |
Ref: Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas. PMID: 7703527 Ref: Enhancement of the cytotoxicity of cisplatin by the cholecystokinin antagonist MK-329 in a human pancreatic cancer cell line. PMID: 7923559 Ref: Effects of raw soya diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster. PMID: 8033071 Ref: Effect of cholecystokinin analogue caerulein and cholecystokinin antagonist lorglumide on pancreatic carcinogenesis in the rat. PMID: 8065144 Ref: Cholecystokinin analog, JMV-180, stimulates growth of human pancreatic cancer. PMID: 8174413 Ref: Functional coupling between the cyclic adenosine monophosphate pathway and cholecystokinin secretion in RIN cells. PMID: 8185590 Ref: Identification and characterization of CCK-B/gastrin receptors in human pancreatic cancer cell lines. PMID: 8304551 |
Ref: Profound duodenogastric reflux causes pancreatic growth in rats. PMID: 7890218 |
Ref: Autoradiographic localization of cholecystokinin (CCK) receptor expression during the development of azaserine-induced rat pancreatic carcinoma. PMID: 8899801 Ref: Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion. PMID: 8928909 |
Ref: Transfected cholecystokinin receptors mediate growth inhibitory effects on human pancreatic cancer cell lines. PMID: 9041258 Ref: Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas. PMID: 9166939 Ref: Infusion of CCK-A receptor mRNA antisense oligodeoxynucleotides inhibits lordosis behavior. PMID: 9272661 Ref: Effects of high-fat diet and cholecystokinin receptor blockade on promotion of pancreatic ductal cell tumors in the hamster. PMID: 9343829 |
Ref: The molecular and cellular biology of pancreatic cancer. PMID: 9807701 Ref: Cholecystokinin receptors in human pancreatic cancer cell lines. PMID: 9849431 |
Ref: Long-term effects on the regulation of pancreatic secretion after gastric surgery. PMID: 10207236 Ref: Cholecystokinin regulates the invasiveness of human pancreatic cancer cell lines via protein kinase C pathway. PMID: 10339669 Ref: Serum cholecystokinin and neurotensin during follow-up of pancreas, prostate and medullary thyroid tumors. PMID: 10365121 Ref: Other risk factors for pancreatic cancer: hormonal aspects. PMID: 10436805 Ref: Cholecystokinin-A receptor messenger RNA expression in human pancreatic cancer. PMID: 10457335 Ref: Regulation of cholecystokinin-mediated amylase secretion by leptin in rat pancreatic acinar tumor cell line AR42J. PMID: 10505752 Ref: The effect of bombesin, cholecystokinin, gastrin, and their antagonists on proliferation of pancreatic cancer cell lines. PMID: 10636070 |
Ref: Response of rat exocrine pancreas to high-fat and high-carbohydrate diets. PMID: 10719845 Ref: Inhibitory effect of a long-acting somatostatin analogue on EGF-stimulated cell proliferation in Capan-2 cells. PMID: 10761690 Ref: Closing the gastrin loop in pancreatic carcinoma: coexpression of gastrin and its receptor in solid human pancreatic adenocarcinoma. PMID: 10861424 |
Ref: Differential expression of gastrin, cholecystokinin-A and cholecystokinin-B receptor mRNA in human pancreatic cancer cell lines. PMID: 11444473 Ref: Effects of lectins on CCK-8-stimulated enzyme secretion and differentiation of the rat pancreatic cell line AR42J. PMID: 11668205 |
Ref: Monitoring of tumour glucose metabolism by PET in a phase I study evaluating hormonal therapy in advanced pancreatic cancer. PMID: 12229975 Ref: Characterization of the CCK-C (cancer) receptor in human pancreatic cancer. PMID: 12429993 Ref: Involvement of cholecystokinin/gastrin-related peptides and their receptors in clinical gastrointestinal disorders. PMID: 12688377 |
Ref: The anti-inflammatory effect of methylprednisolone occurs down-stream of nuclear factor-kappaB DNA binding in acute pancreatitis. PMID: 12620516 Ref: Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue. PMID: 12851875 Ref: Mechanisms of alcoholic pancreatitis. Proceedings of a conference. Chicago, Illinois, USA, November 2002. PMID: 14576487 Ref: Rapid endoscopic secretin stimulation test and discrimination of chronic pancreatitis and pancreatic cancer from disease controls. PMID: 15017660 |
Ref: Gastrins, cholecystokinins and gastrointestinal cancer. PMID: 15238241 Ref: Does neoplastic cholecystokinin expression reflect the embryonal pattern of the protein? A study in human pancreas. PMID: 15446358 Ref: What are the pancreatic target cells for gastrin and its CCKB receptor? Is this a couple for cancerous cells? PMID: 15448615 Ref: (111)In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-HHHHHH-EAYGWMDF-NH2 peptide PMID: 20641278 Ref: (111)In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-HHEAYGWMDF-NH2 peptide PMID: 20641328 Ref: (111)In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-dihistidine-norleucine peptide analog PMID: 20641374 Ref: [(99m)Tc(N)(NS-Cys-Gly-CCK-8)(PNP3)](+) PMID: 20641448 Ref: (99m)Tc-Ethylenediaminediacetic acid/hydrazinonicotinamide-[dGlu(1)]minigastrin PMID: 20641776 Ref: (99m)Tc-Tricarbonyl-K-H-K-H-cholecystokinin 8 PMID: 20641941 Ref: (111)In/(68)Ga-Labeled DOTA-conjugated cyclo[gamma-d-Glu-Ala-Tyr-d-Lys]-Trp-Met-Asp-Phe-NH2 (cyclo-MG1), a minigastrin analog PMID: 22787691 Ref: (111)In/(68)Ga-Labeled DOTA conjugated cyclo[gamma-d-Glu-Ala-Tyr-d-Lys]-Trp-Nle-Asp-Phe-NH2 (cyclo-MG2), a minigastrin analog PMID: 22855967 Ref: (68)Ga-Labeled DOTA-conjugated sCCK8[Phe(2)(p-CH2SO3H),Nle(3,6)], a sulfated cholecystokinin 8 (sCCK8) peptide derivative PMID: 23390663 Ref: (111)In-Labeled DOTA-conjugated sCCK8[Phe(2)(p-CH2SO3H),Nle(3,6)], a sulfated cholecystokinin 8 (sCCK8) peptide derivative PMID: 23390667 |
Ref: Presence of CCK-A, B receptors and effect of gastrin and cholecystokinin on growth of pancreatobiliary cancer cell lines. PMID: 15682471 Ref: Analysis of the cellular and molecular mechanisms of trophic action of a misspliced form of the type B cholecystokinin receptor present in colon and pancreatic cancer. PMID: 15837546 Ref: [Construction of recombinant plasmid pIRES2-EGFP/CCK and its expression in vivo and in vitro]. PMID: 16235518 |
Ref: Suppression of pancreatic tumor progression by systemic delivery of a pancreatic-cancer-specific promoter driven Bik mutant. PMID: 15953675 Ref: [Construction of recombinant plasmid pIRES2-EGFP/CCK and its expression in vivo and in vitro]. PMID: 16562664 Ref: Possible role of duration of PKC-induced ERK activation in the effects of agonists and phorbol esters on DNA synthesis in Panc-1 cells. PMID: 16637058 Ref: Gene therapeutic treatment of pancreatic cancer based on injection of pcDNA3.1/CCK plasmid with xenogeneic homologous cholecystokinin. PMID: 16837905 |
Ref: Construction of porcine CCK pDNA and its expression in COS-7 cells. PMID: 17641841 Ref: Immunoelectron study of pancreatic carcinomas using antibodies to gastrointestinal hormones. PMID: 17786831 |
Ref: Effects of lorglumide on growth and invasion of human pancreatic cancer cell line Mia PaCa-2 in vitro through the cholecystokinin-cholecystokinin-1 receptor pathway. PMID: 24688146 |
Ref: Role of endogenous cholecystokinin on growth of human pancreatic cancer. PMID: 21186400 Ref: Expression of multiple forms of 3'-end variant CCK2 receptor mRNAs in human pancreatic adenocarcinomas. PMID: 21504585 |
Ref: Role of janus kinase/signal transducers and activators of transcription in the pathogenesis of pancreatitis and pancreatic cancer. PMID: 23170143 |
Ref: Synthesis and evaluation of cholecystokinin trimers: a multivalent approach to pancreatic cancer detection and treatment. PMID: 23489620 |
Ref: Cholecystokinin and pancreatic cancer: the chicken or the egg? PMID: 24177032 Ref: Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat. PMID: 24817409 Ref: Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice. PMID: 25058882 |
Ref: Distribution of cholecystokinin-B receptor genotype between patients with pancreatic cancer and controls and its impact on survival. PMID: 25469546 Ref: Immunohistochemical examination of cholecystokinin and gastrin receptors (CCK-2/gastrin-R) expression in normal and exocrine cancerous human pancreatic tissues. PMID: 26520651 |
Ref: Germline Mutation of the CCK Receptor: A Novel Biomarker for Pancreas Cancer. PMID: 26741064 Ref: The Role of Gastrin and CCK Receptors in Pancreatic Cancer and other Malignancies. PMID: 26929735 Ref: The Significance of Ras Activity in Pancreatic Cancer Initiation. PMID: 26929740 |
Ref: Effects of Melatonin and Its Analogues on Pancreatic Inflammation, Enzyme Secretion, and Tumorigenesis. PMID: 28481310 Ref: Less common etiologies of exocrine pancreatic insufficiency. PMID: 29093615 Ref: Identification of potent cholecystokinin-B receptor antagonists: synthesis, molecular modeling and anti-cancer activity against pancreatic cancer cells. PMID: 30108868 |
Ref: Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice. PMID: 29043413 Ref: Dietary Fat Stimulates Pancreatic Cancer Growth and Promotes Fibrosis of the Tumor Microenvironment through the Cholecystokinin Receptor. PMID: 29927319 |